We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
-6.53%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$31.1M
Cap. Flow
+$160M
Cap. Flow %
7.34%
Top 10 Hldgs %
25.32%
Holding
187
New
40
Increased
44
Reduced
62
Closed
37

Top Sells

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$42.5M
2
ACHC icon
Acadia Healthcare
ACHC
+$38.6M
3
CNXC icon
Concentrix
CNXC
+$36.4M
4
VTRS icon
Viatris
VTRS
+$33.1M
5
MTB icon
M&T Bank
MTB
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 30.56%
2 Healthcare 19.11%
3 Consumer Discretionary 12.35%
4 Industrials 11.07%
5 Consumer Staples 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
51
Zimmer Biomet
ZBH
$19.3B
$15.3M 0.7%
169,706
+35,848
+27% +$3.29M
SPSC icon
52
SPS Commerce
SPSC
$2.9B
$14.7M 0.67%
+264,095
New +$19M
CENTA icon
53
Central Garden & Pet Co Class A
CENTA
$2.39B
$14.6M 0.67%
451,328
-19,687
-4% -$628K
RYZ
54
Ryerson Holding Corp
RYZ
$1.31B
$14.5M 0.66%
644,284
-9,230
-1% -$241K
SSTK icon
55
Shutterstock
SSTK
$205M
$14.3M 0.66%
859,637
+124,688
+17% +$2.2M
FIVN icon
56
FIVE9
FIVN
$2.39B
$14.2M 0.65%
936,788
+670,536
+252% +$11.7M
MTN icon
57
Vail Resorts
MTN
$5.3B
$14.2M 0.65%
110,543
+74,278
+205% +$10.1M
MNDY icon
58
monday.com
MNDY
$3.91B
$13.9M 0.64%
+200,517
New +$19.2M
RIVN icon
59
CALL
Rivian
RIVN
$23.6B
$13.4M 0.61%
+890,000
New +$14.2M
PRU icon
60
Prudential Financial
PRU
$41.5B
$11.7M 0.54%
+119,651
New +$12.4M
CAL icon
61
Caleres
CAL
$440M
$11.6M 0.53%
1,104,013
+72,139
+7% +$860K
OGG
62
Osisko Gold Group
OGG
$942M
$11.6M 0.53%
3,563,786
+1,353,639
+61% +$5.03M
PRKS icon
63
United Parks & Resorts
PRKS
$1.96B
$11.6M 0.53%
353,782
+44,774
+14% +$1.57M
ZD icon
64
Ziff Davis
ZD
$1.91B
$10.9M 0.5%
260,392
-297,221
-53% -$10.9M
LAZ icon
65
Lazard
LAZ
$4.17B
$10.9M 0.5%
+256,750
New +$12.6M
EPC icon
66
Edgewell Personal Care
EPC
$1.32B
$10.6M 0.48%
494,748
-21,930
-4% -$442K
FLGT icon
67
Fulgent Genetics
FLGT
$545M
$9.7M 0.45%
+610,318
New +$13.2M
CART icon
68
Maplebear
CART
$11.8B
$9.55M 0.44%
255,043
-14,283
-5% -$542K
IART icon
69
Integra LifeSciences
IART
$1.31B
$9.53M 0.44%
1,011,315
-44,626
-4% -$490K
GOOS
70
Canada Goose Holdings
GOOS
$793M
$9.39M 0.43%
+856,253
New +$10.3M
FLO icon
71
Flowers Foods
FLO
$1.52B
$9.38M 0.43%
1,150,339
+537,884
+88% +$5.4M
HELE icon
72
Helen of Troy
HELE
$679M
$9.37M 0.43%
649,459
+56,149
+9% +$982K
PCTY icon
73
Paylocity
PCTY
$8.07B
$9.28M 0.43%
+85,938
New +$10.5M
OVV icon
74
Ovintiv
OVV
$17.8B
$9.11M 0.42%
153,463
-8,244
-5% -$398K
BL icon
75
BlackLine
BL
$1.82B
$8.7M 0.4%
+235,012
New +$10.1M

Similar funds

Invenomic Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Invenomic Capital Management held 187 positions worth $2.18B, up 1.4% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $160M of net new capital in Q1 2026, opening 40 new positions and adding to 44 existing holdings. Its largest new stake was Workday: 559,955 shares worth $72.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Acadia Healthcare, an estimated $38.6M trimmed.

  • Invenomic Capital Management's largest Q1 2026 buy was Workday: 559,955 shares worth $72.7M.
  • Invenomic Capital Management added most to Fidelity National Information Services in Q1 2026, an estimated $41.7M increase.
  • Invenomic Capital Management's biggest Q1 2026 reduction was Acadia Healthcare, cutting an estimated $38.6M.
  • Invenomic Capital Management fully exited Equinox Gold in Q1 2026, selling an estimated $42.5M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.18B portfolio in Q1 2026.
  • Invenomic Capital Management opened 40 new positions and closed 37 in Q1 2026.
  • Invenomic Capital Management's portfolio value rose 1.4% quarter-over-quarter to $2.18B.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.